Impact of housing on the survival of persons with AIDS

Schwarcz, Sandra K.; Hsu, Ling C.; Vittinghoff, Eric; Vu, Annie; Bamberger, Joshua D.; Katz, Mitchell H.
January 2009
BMC Public Health;2009, Vol. 9 Issue 1, p220
Academic Journal
Background: Homeless persons with HIV/AIDS have greater morbidity and mortality, more hospitalizations, less use of antiretroviral therapy, and worse medication adherence than HIV-infected persons who are stably housed. We examined the effect of homelessness on the mortality of persons with AIDS and measured the effect of supportive housing on AIDS survival. Methods: The San Francisco AIDS registry was used to identify homeless and housed persons who were diagnosed with AIDS between 1996 and 2006. The registry was computer-matched with a housing database of homeless persons who received housing after their AIDS diagnosis. The Kaplan-Meier product limit method was used to compare survival between persons who were homeless at AIDS diagnosis and those who were housed. Proportional hazards models were used to estimate the independent effects of homelessness and supportive housing on survival after AIDS diagnosis. Results: Of the 6,558 AIDS cases, 9.8% were homeless at diagnosis. Sixty-seven percent of the persons who were homeless survived five years compared with 81% of those who were housed (p < 0.0001). Homelessness increased the risk of death (adjusted relative hazard [RH] 1.20; 95% confidence limits [CL] 1.03, 1.41). Homeless persons with AIDS who obtained supportive housing had a lower risk of death than those who did not (adjusted RH 0.20; 95% CL 0.05, 0.81). Conclusion: Supportive housing ameliorates the negative effect of homelessness on survival with AIDS.


Related Articles

  • Impact of HIV/Aids on Child Mortality before the Highly Active Antiretroviral Therapy Era: A Study in Pointe-Noire, Republic of Congo. Lallemant, Camille; Halembokaka, Gaston; Baty, Gaelle; Ngo-Giang-Huong, Nicole; Barin, Francis; Le Coeur, Sophie // Journal of Tropical Medicine (16879686);2010, p1 

    Few studies have documented the contribution of HIV/AIDS to mortality among children under 15 years. From June 30 to October 19, 2001, all child deaths (n = 588) registered to the morgue and/or hospitals of the city of Pointe-Noire, Congo, were investigated using a combined approach including an...

  • How does HIV impact on non-AIDS events in the era of HAART? Barber, T. J.; Hughes, A.; Dinsmore, W. W.; Phillips, A. // International Journal of STD & AIDS;Jan2009, Vol. 20 Issue 1, p1 

    Death rates from AIDS-related events in HIV-positive individuals have declined in the era of highly active antiretroviral therapy (HAART). It has also been shown that deaths from non-AIDS events have declined in this cohort since the advent of HAART. We review these data, as well as discussing...

  • Disparities in the Burden of HIV/AIDS in Canada. Hogg, Robert S.; Heath, Katherine; Lima, Viviane D.; Nosyk, Bohdan; Kanters, Steve; Wood, Evan; Kerr, Thomas; Montaner, Julio S. G. // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Background: We aimed to characterize changes in patterns of new HIV diagnoses, HIV-related mortality, and HAART use in Canada from 1995 to 2008. Methods: Data on new HIV diagnoses were obtained from Health Canada, HIV-related mortality statistics were obtained from Statistics Canada, and...

  • Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort.  // AIDS Research & Therapy;2012, Vol. 9, p4 

    The article offers information on a study conducted by the authors to identify factors which lead to risk of highly active antiretroviral therapy (HAART) mortality in HIV patients in the U.S. The authors evaluated baseline before HAART for associations with mortality in patients who began HAART...

  • Results of the Expanded HIV Testing Initiative -- 25 Jurisdictions, United States, 2007-2010. Viall, Abigail H.; Dooley, Samuel W.; Branson, Bernard M.; Duffy, Nadezhda; Mermin, Jonathan; Cleveland, Janet C.; Cagle, Chris; Lyon, Wendy A. // MMWR: Morbidity & Mortality Weekly Report;6/24/2011, Vol. 60 Issue 24, p805 

    The article discusses the outcomes of the expanded testing initiative concerning the human immunodeficiency virus (HIV) in the U.S. from 2007 to 2010. It estimates that around 20 per cent of the total population of U.S. people who are infected with the virus in 2008 were not aware of their...

  • Task shifting in Mozambique: cross-sectional evaluation of non-physician clinicians' performance in HIV/AIDS care. Brentlinger, Paula E.; Assan, Américo; Mudender, Florindo; Ghee, Annette E.; Torres, José Vallejo; Martínez, Pilar Martínez; Bacon, Oliver; Bastos, Rui; Manuel, Rolanda; Li, Lucy Ramirez; McKinney, Catherine; Nelson, Lisa J. // Human Resources for Health;2010, Vol. 8, p23 

    Background: Many resource-constrained countries now train non-physician clinicians in HIV/AIDS care, a strategy known as 'task-shifting.' There is as yet no evidence-based international standard for training these cadres. In 2007, the Mozambican Ministry of Health (MOH) conducted a nationwide...

  • Gebe ve Ä°lerlemiÅŸ Bir HIV/AIDS Olgusu. Aydın, Özlem Altuntaş; Karaosmanoğlu, Hayat Kumbasar; Korkusuz, Ramazan; Nazlıcan, Özcan // Medical Bulletin of Haseki / Haseki Tip Bulteni;Mar2011, Vol. 49 Issue 1, p39 

    After the introduction of highly active antiretroviral therapy (HAART), the life quality and life expectancy of HIV/AIDS patients have improved. Although the AIDS women of reproductive age are willing to give birth, they are anxious about the possibility of infection in the newborn. In addition...

  • Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328). Bosch, Ronald J.; Pollard, Richard B.; Landay, Alan; Aga, Evgenia; Fox, Lawrence; Mitsuyasu, Ronald // AIDS Research & Therapy;2010, Vol. 7, p30 

    Background: Effective antiretroviral therapy reduces HIV-1 RNA levels, improves CD4 T-cell counts, and lowers the risk of opportunistic infections and malignancies. Interleukin-2 (IL-2) has been shown to increase CD4 T-cell numbers mainly by expanding CD4 cells and by prolonging their...

  • Treatment Outcomes in Patients Receiving Combination Antiretroviral Therapy in Central Hospital, Benin City, Nigeria. Agu, Kenneth A.; Ochei, Uche M.; Oparah, Azuka C.; Onoh, Obialunamma U. // Tropical Journal of Pharmaceutical Research;Feb2010, Vol. 9 Issue 1, p1 

    Purpose: This study investigated mortality rate, early CD4 responses, pattern of ARVs substitutions and medication adherence of HIV-infected patients on first-line triple combination antiretroviral therapy (ART) in Central Hospital, Benin City, Nigeria. Methods: A retrospective assessment of 196...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics